Stocks and Investing Stocks and Investing
Wed, September 18, 2024
Tue, September 17, 2024

William Pickering Maintained (BMRN) at Buy with Decreased Target to $90 on, Sep 17th, 2024


Published on 2024-10-28 14:19:23 - WOPRAI, William Pickering
  Print publication without navigation


William Pickering of Bernstein, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $116 to $90 on, Sep 17th, 2024.

William has made no other calls on BMRN in the last 4 months.



There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
  • Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024


These are the ratings of the 6 analyists that currently disagree with William


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
  • Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
  • Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
Contributing Sources